Yubo International Biotech Ltd. engages in the supply of products that process, store, and administer therapeutic doses of endometrial stem cells for the treatment of disease and injuries. The company is headquartered in Beijing, Beijing and currently employs 18 full-time employees. The firm focuses on the research and development and application of endometrial stem cells and offers its products and services under the brand VIVCELL. The Company’s product offerings include healthcare products for respiratory system, skincare products, hair care products, healthy beverages and male and female personal care products. The firm also offers stem cell related services including cell testing and health management consulting services.
YBGJ stock price ended at $0.01 on 星期一, after dropping 50.00%
On the latest trading day Apr 06, 2026, the stock price of YBGJ fell by 50.00%, dropping from $0.01 to $0.01. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.01 and a high of $0.01. On the latest trading day, the trading volume for YBGJ decreased by 10.0K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 10.0K shares were traded, with a market value of approximately $1.7M.